APA

Lim Z. Y., Ingram W., Brand R., Akthari M., Milojkovic D., Ho A. Y. L., Devereux S., Pagliuca A., Duarte R. F. & Mufti G. J. (20071220). Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. : Bone marrow transplantation.

Chicago

Lim Z Y, Ingram W, Brand R, Akthari M, Milojkovic D, Ho A Y L, Devereux S, Pagliuca A, Duarte R F and Mufti G J. 20071220. Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. : Bone marrow transplantation.

Harvard

Lim Z. Y., Ingram W., Brand R., Akthari M., Milojkovic D., Ho A. Y. L., Devereux S., Pagliuca A., Duarte R. F. and Mufti G. J. (20071220). Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. : Bone marrow transplantation.

MLA

Lim Z Y, Ingram W, Brand R, Akthari M, Milojkovic D, Ho A Y L, Devereux S, Pagliuca A, Duarte R F and Mufti G J. Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. : Bone marrow transplantation. 20071220.